Literature DB >> 13413647

Laboratory and vaccination studies with dried smallpox vaccines.

W C COCKBURN, R M CROSS, A W DOWNIE, K R DUMBELL, C KAPLAN, D MCCLEAN, A M PAYNE.   

Abstract

In a vaccination and laboratory study, two dried smallpox vaccines (designated P and Q) were tested at intervals of 4, 8, 16, and 32 weeks after storage at both 37 degrees C and 45 degrees C. Vaccine P was also tested after 64 weeks at these temperatures and gave 100% successful vaccination rates after all periods of storage at both temperatures. Vaccine Q deteriorated within four weeks, rapidly at 45 degrees C and less rapidly, but very substantially, at 37 degrees C. There was no clear evidence of the cause of this deterioration, but there was a suggestion of denaturation of some of the samples stored at the higher temperature. So far as could be ascertained, the laboratory results-rabbit skin scarification tests and chorio-allantoic membrane pock counts-ran parallel with the vaccination success rates. The pock count was found to be the more accurate method of laboratory titration. Vaccine P as used in the trial was not an exceptional batch.Vaccines which give a pock count of 10(8) infective units per ml will give the highest possible rate of successful primary vaccinations.A statistical note on the trials is given in an annex.

Entities:  

Keywords:  SMALLPOX/immunology

Mesh:

Substances:

Year:  1957        PMID: 13413647      PMCID: PMC2538200     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  The development of a stable smallpox vaccine.

Authors:  L H COLLIER
Journal:  J Hyg (Lond)       Date:  1955-03

2.  Dried smallpox vaccine.

Authors:  J W HORNIBROOK; W H GEBHARD
Journal:  Public Health Rep       Date:  1951-01-12       Impact factor: 2.792

  2 in total
  11 in total

1.  TISSUE CULTURE END-POINT TITRATIONS AS A ROUTINE POTENCY TEST FOR SMALLPOX VACCINE.

Authors:  J A ESPMARK
Journal:  Arch Gesamte Virusforsch       Date:  1964-09-09

2.  Relationship between pock counts on chorio-allantoic membrane and percentages of "takes" in primary vaccination of human beings with two smallpox vaccines.

Authors:  M F POLAK; L M BRANS; J BEUNDERSB; A van der WERFF
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

3.  Studies with dried and glycerinated smallpox vaccines of full and diminished potencies.

Authors:  R M CROSS; C KAPLAN; D McCLEAN
Journal:  Bull World Health Organ       Date:  1958       Impact factor: 9.408

4.  A comparison of the rabbit scarification technique with titrations in cell cultures for the potency assay of smallpox vaccine.

Authors:  R W KOLB; E C CUTCHINS; W P JONES; H T AYLOR
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

5.  Titration of vaccinia virus by intravenous injection of chick embryos.

Authors:  C KAPLAN
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

6.  Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high-throughput assay.

Authors:  Richard Kennedy; V Shane Pankratz; Eric Swanson; David Watson; Hana Golding; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2009-06-17

7.  Comparison of titrations on the chorioallantoic membrane of chick embryos with the rabbit scarification technique for the potency assay of smallpox vaccines.

Authors:  V J Fuller; R W Kolb
Journal:  Appl Microbiol       Date:  1968-03

8.  Assay of neutralizing antibody against variola virus by the degree of focus reduction on HeLa cell cultures and its application to revaccination with smallpox vaccines of various potencies.

Authors:  T Kitamura; N Shinjo
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

9.  Developing new smallpox vaccines.

Authors:  S R Rosenthal; M Merchlinsky; C Kleppinger; K L Goldenthal
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

10.  Frequency of adverse events after vaccination with different vaccinia strains.

Authors:  Mirjam Kretzschmar; Jacco Wallinga; Peter Teunis; Shuqin Xing; Rafael Mikolajczyk
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.